BCMA-Targeted T-Cell-Engager Therapy for Autoimmune Disease.

Autor: Hagen M; Friedrich Alexander University Erlangen-Nuremberg , Erlangen, Germany., Bucci L; Friedrich Alexander University Erlangen-Nuremberg , Erlangen, Germany., Böltz S; Friedrich Alexander University Erlangen-Nuremberg , Erlangen, Germany., Nöthling DM; Friedrich Alexander University Erlangen-Nuremberg , Erlangen, Germany., Rothe T; Friedrich Alexander University Erlangen-Nuremberg , Erlangen, Germany., Anoshkin K; Friedrich Alexander University Erlangen-Nuremberg , Erlangen, Germany., Raimondo MG; Friedrich Alexander University Erlangen-Nuremberg , Erlangen, Germany., Tur C; Friedrich Alexander University Erlangen-Nuremberg , Erlangen, Germany., Wirsching A; Friedrich Alexander University Erlangen-Nuremberg , Erlangen, Germany., Wacker J; Friedrich Alexander University Erlangen-Nuremberg , Erlangen, Germany., Düsing C; Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Distler JHW; Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Kuwert T; Friedrich Alexander University Erlangen-Nuremberg , Erlangen, Germany ricardo.grieshaber@fau.de., Bozec A; Friedrich Alexander University Erlangen-Nuremberg , Erlangen, Germany ricardo.grieshaber@fau.de., Ramming A; Friedrich Alexander University Erlangen-Nuremberg , Erlangen, Germany ricardo.grieshaber@fau.de., Schett G; Friedrich Alexander University Erlangen-Nuremberg , Erlangen, Germany ricardo.grieshaber@fau.de., Grieshaber-Bouyer R; Friedrich Alexander University Erlangen-Nuremberg , Erlangen, Germany ricardo.grieshaber@fau.de.
Jazyk: angličtina
Zdroj: The New England journal of medicine [N Engl J Med] 2024 Sep 05; Vol. 391 (9), pp. 867-869.
DOI: 10.1056/NEJMc2408786
Databáze: MEDLINE